-
1
-
-
59449098985
-
Gene therapy for immunodeficiency due to adenosine deaminase deficiency
-
Aiuti A., Cattaneo F., Galimberti S., Benninghoff U., Cassani B., Callegaro L., Scaramuzza S., Andolfi G., Mirolo M., Brigida I., Tabucchi A., Carlucci F., Eibl M., Aker M., Slavin S., Al-Mousa H., Al Ghonaium A., Ferster A., Duppenthaler A., Notarangelo L., Wintergerst U., Buckley R.H., Bregni M., Marktel S., Valsecchi M.G., Rossi P., Ciceri F., Miniero R., Bordignon C., Roncarolo M.G. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 2009, 360(5):447-458.
-
(2009)
N. Engl. J. Med.
, vol.360
, Issue.5
, pp. 447-458
-
-
Aiuti, A.1
Cattaneo, F.2
Galimberti, S.3
Benninghoff, U.4
Cassani, B.5
Callegaro, L.6
Scaramuzza, S.7
Andolfi, G.8
Mirolo, M.9
Brigida, I.10
Tabucchi, A.11
Carlucci, F.12
Eibl, M.13
Aker, M.14
Slavin, S.15
Al-Mousa, H.16
Al Ghonaium, A.17
Ferster, A.18
Duppenthaler, A.19
Notarangelo, L.20
Wintergerst, U.21
Buckley, R.H.22
Bregni, M.23
Marktel, S.24
Valsecchi, M.G.25
Rossi, P.26
Ciceri, F.27
Miniero, R.28
Bordignon, C.29
Roncarolo, M.G.30
more..
-
2
-
-
77952577744
-
Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies
-
Alanio C., Lemaitre F., Law H.K., Hasan M., Albert M.L. Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. Blood 2010, 115(18):3718-3725.
-
(2010)
Blood
, vol.115
, Issue.18
, pp. 3718-3725
-
-
Alanio, C.1
Lemaitre, F.2
Law, H.K.3
Hasan, M.4
Albert, M.L.5
-
3
-
-
0030018156
-
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
-
Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272(5270):1955-1958.
-
(1996)
Science
, vol.272
, Issue.5270
, pp. 1955-1958
-
-
Alkhatib, G.1
Combadiere, C.2
Broder, C.C.3
Feng, Y.4
Kennedy, P.E.5
Murphy, P.M.6
Berger, E.A.7
-
4
-
-
79953117041
-
Evidence for the cure of HIV infection by CCR5δ32/δ32 stem cell transplantation
-
doi:10.1182/blood-2010-09-309591
-
Allers, K., Hütter, G., Hofmann J., Loddenkemper, C., Rieger, K., Thiel, E., Schneider, T., 2010. Evidence for the cure of HIV infection by CCR5δ32/δ32 stem cell transplantation. doi:10.1182/blood-2010-09-309591.
-
(2010)
-
-
Allers, K.1
Hütter, G.2
Hofmann, J.3
Loddenkemper, C.4
Rieger, K.5
Thiel, E.6
Schneider, T.7
-
5
-
-
48249088137
-
Dynamics of Immune Escape during HIV/SIV Infection
-
Althaus C.L., De Boer R.J. Dynamics of Immune Escape during HIV/SIV Infection. PLoS Comput. Biol. 2008, 4(7):e1000103.
-
(2008)
PLoS Comput. Biol.
, vol.4
, Issue.7
-
-
Althaus, C.L.1
De Boer, R.J.2
-
6
-
-
12144291445
-
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients
-
Amado R.G., Mitsuyasu R.T., Rosenblatt J.D., Ngok F.K., Bakker A., Cole S., Chorn N., Lin L.S., Bristol G., Boyd M.P., MacPherson J.L., Fanning G.C., Todd A.V., Ely J.A., Zack J.A., Symonds G.P. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum. Gene Ther. 2004, 15(3):251-262.
-
(2004)
Hum. Gene Ther.
, vol.15
, Issue.3
, pp. 251-262
-
-
Amado, R.G.1
Mitsuyasu, R.T.2
Rosenblatt, J.D.3
Ngok, F.K.4
Bakker, A.5
Cole, S.6
Chorn, N.7
Lin, L.S.8
Bristol, G.9
Boyd, M.P.10
MacPherson, J.L.11
Fanning, G.C.12
Todd, A.V.13
Ely, J.A.14
Zack, J.A.15
Symonds, G.P.16
-
7
-
-
33748438866
-
Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors
-
An D.S., Qin F.X., Auyeung V.C., Mao S.H., Kung S.K., Baltimore D., Chen I.S. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol. Ther. 2006, 14(4):494-504.
-
(2006)
Mol. Ther.
, vol.14
, Issue.4
, pp. 494-504
-
-
An, D.S.1
Qin, F.X.2
Auyeung, V.C.3
Mao, S.H.4
Kung, S.K.5
Baltimore, D.6
Chen, I.S.7
-
8
-
-
34548779028
-
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates
-
An D.S., Donahue R.E., Kamata M., Poon B., Metzger M., Mao S.H., Bonifacino A., Krouse A.E., Darlix J.L., Baltimore D., Qin F.X., Chen I.S. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc. Natl Acad. Sci. USA 2007, 104(32):13110-13115.
-
(2007)
Proc. Natl Acad. Sci. USA
, vol.104
, Issue.32
, pp. 13110-13115
-
-
An, D.S.1
Donahue, R.E.2
Kamata, M.3
Poon, B.4
Metzger, M.5
Mao, S.H.6
Bonifacino, A.7
Krouse, A.E.8
Darlix, J.L.9
Baltimore, D.10
Qin, F.X.11
Chen, I.S.12
-
9
-
-
33845221484
-
HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector
-
Anderson J., Akkina R. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res. Ther. 2005, 2(1):1.
-
(2005)
AIDS Res. Ther.
, vol.2
, Issue.1
, pp. 1
-
-
Anderson, J.1
Akkina, R.2
-
10
-
-
41149134501
-
Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue
-
Anderson J., Akkina R. Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue. Hum. Gene Ther. 2008, 19(3):217-228.
-
(2008)
Hum. Gene Ther.
, vol.19
, Issue.3
, pp. 217-228
-
-
Anderson, J.1
Akkina, R.2
-
11
-
-
1642564331
-
Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance
-
Anderson J., Banerjea A., Akkina R. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides 2003, 13(5):303-312.
-
(2003)
Oligonucleotides
, vol.13
, Issue.5
, pp. 303-312
-
-
Anderson, J.1
Banerjea, A.2
Akkina, R.3
-
12
-
-
33646799733
-
Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy
-
Anderson J.S., Bandi S., Kaufman D.S., Akkina R. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology 2006, 3:24.
-
(2006)
Retrovirology
, vol.3
, pp. 24
-
-
Anderson, J.S.1
Bandi, S.2
Kaufman, D.S.3
Akkina, R.4
-
13
-
-
34249336747
-
Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cells
-
Anderson J., Li M.J., Palmer B., Remling L., Li S., Yam P., Yee J.K., Rossi J., Zaia J., Akkina R. Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cells. Mol. Ther. 2007, 15(6):1182-1188.
-
(2007)
Mol. Ther.
, vol.15
, Issue.6
, pp. 1182-1188
-
-
Anderson, J.1
Li, M.J.2
Palmer, B.3
Remling, L.4
Li, S.5
Yam, P.6
Yee, J.K.7
Rossi, J.8
Zaia, J.9
Akkina, R.10
-
14
-
-
73849124989
-
Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy
-
Anderson J.S., Javien J., Nolta J.A., Bauer G. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Mol. Ther. 2009, 17(12):2103-2114.
-
(2009)
Mol. Ther.
, vol.17
, Issue.12
, pp. 2103-2114
-
-
Anderson, J.S.1
Javien, J.2
Nolta, J.A.3
Bauer, G.4
-
15
-
-
0033952103
-
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
-
Baba T.W., Liska V., Hofmann-Lehmann R., Vlasak J., Xu W., Ayehunie S., Cavacini L.A., Posner M.R., Katinger H., Stiegler G., Bernacky B.J., Rizvi T.A., Schmidt R., Hill L.R., Keeling M.E., Lu Y., Wright J.E., Chou T.C., Ruprecht R.M. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 2000, 6(2):200-206.
-
(2000)
Nat. Med.
, vol.6
, Issue.2
, pp. 200-206
-
-
Baba, T.W.1
Liska, V.2
Hofmann-Lehmann, R.3
Vlasak, J.4
Xu, W.5
Ayehunie, S.6
Cavacini, L.A.7
Posner, M.R.8
Katinger, H.9
Stiegler, G.10
Bernacky, B.J.11
Rizvi, T.A.12
Schmidt, R.13
Hill, L.R.14
Keeling, M.E.15
Lu, Y.16
Wright, J.E.17
Chou, T.C.18
Ruprecht, R.M.19
-
16
-
-
0035794261
-
Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy
-
Bai J., Rossi J., Akkina R. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy. AIDS Res. Hum. Retroviruses 2001, 17(5):385-399.
-
(2001)
AIDS Res. Hum. Retroviruses
, vol.17
, Issue.5
, pp. 385-399
-
-
Bai, J.1
Rossi, J.2
Akkina, R.3
-
17
-
-
78650664088
-
Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response
-
Balamurugan A., Ng H.L., Yang O.O. Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response. J. Immunol. 2010, 185(10):5935-5942.
-
(2010)
J. Immunol.
, vol.185
, Issue.10
, pp. 5935-5942
-
-
Balamurugan, A.1
Ng, H.L.2
Yang, O.O.3
-
18
-
-
0024299563
-
Gene therapy. Intracellular immunization
-
Baltimore D. Gene therapy. Intracellular immunization. Nature 1988, 335(6189):395-396.
-
(1988)
Nature
, vol.335
, Issue.6189
, pp. 395-396
-
-
Baltimore, D.1
-
19
-
-
43749110294
-
Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection
-
Bandi S., Akkina R. Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection. AIDS Res. Ther. 2008, 5:1.
-
(2008)
AIDS Res. Ther.
, vol.5
, pp. 1
-
-
Bandi, S.1
Akkina, R.2
-
20
-
-
77952236875
-
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
-
1p following 570
-
Bendle G.M., Linnemann C., Hooijkaas A.I., Bies L., de Witte M.A., Jorritsma A., Kaiser A.D., Pouw N., Debets R., Kieback E., Uckert W., Song J.Y., Haanen J.B., Schumacher T.N. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nat. Med. 2010, 16(5):565-570. 1p following 570.
-
(2010)
Nat. Med.
, vol.16
, Issue.5
, pp. 565-570
-
-
Bendle, G.M.1
Linnemann, C.2
Hooijkaas, A.I.3
Bies, L.4
de Witte, M.A.5
Jorritsma, A.6
Kaiser, A.D.7
Pouw, N.8
Debets, R.9
Kieback, E.10
Uckert, W.11
Song, J.Y.12
Haanen, J.B.13
Schumacher, T.N.14
-
21
-
-
70349342731
-
Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells
-
Berry L.J., Moeller M., Darcy P.K. Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells. Tissue Antigens 2009, 74(4):277-289.
-
(2009)
Tissue Antigens
, vol.74
, Issue.4
, pp. 277-289
-
-
Berry, L.J.1
Moeller, M.2
Darcy, P.K.3
-
22
-
-
0142124143
-
Human immunodeficiency virus type 1 escape from RNA interference
-
Boden D., Pusch O., Lee F., Tucker L., Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 2003, 77(21):11531-11535.
-
(2003)
J. Virol.
, vol.77
, Issue.21
, pp. 11531-11535
-
-
Boden, D.1
Pusch, O.2
Lee, F.3
Tucker, L.4
Ramratnam, B.5
-
23
-
-
0029149833
-
Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins
-
Bogerd H.P., Fridell R.A., Madore S., Cullen B.R. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 1995, 82(3):485-494.
-
(1995)
Cell
, vol.82
, Issue.3
, pp. 485-494
-
-
Bogerd, H.P.1
Fridell, R.A.2
Madore, S.3
Cullen, B.R.4
-
24
-
-
1642367210
-
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
-
Bogerd H.P., Doehle B.P., Wiegand H.L., Cullen B.R. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl Acad. Sci. USA 2004, 101(11):3770-3774.
-
(2004)
Proc. Natl Acad. Sci. USA
, vol.101
, Issue.11
, pp. 3770-3774
-
-
Bogerd, H.P.1
Doehle, B.P.2
Wiegand, H.L.3
Cullen, B.R.4
-
25
-
-
1342330261
-
Adoptive immunotherapy for posttransplantation viral infections
-
Bollard C.M., Kuehnle I., Leen A., Rooney C.M., Heslop H.E. Adoptive immunotherapy for posttransplantation viral infections. Biol. Blood Marrow Transplant. 2004, 10(3):143-155.
-
(2004)
Biol. Blood Marrow Transplant.
, vol.10
, Issue.3
, pp. 143-155
-
-
Bollard, C.M.1
Kuehnle, I.2
Leen, A.3
Rooney, C.M.4
Heslop, H.E.5
-
26
-
-
4644342929
-
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
-
Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004, 200(6):749-759.
-
(2004)
J. Exp. Med.
, vol.200
, Issue.6
, pp. 749-759
-
-
Brenchley, J.M.1
Schacker, T.W.2
Ruff, L.E.3
Price, D.A.4
Taylor, J.H.5
Beilman, G.J.6
Nguyen, P.L.7
Khoruts, A.8
Larson, M.9
Haase, A.T.10
Douek, D.C.11
-
27
-
-
42149136000
-
TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis
-
Brennan G., Kozyrev Y., Hu S.L. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl Acad. Sci. USA 2008, 105(9):3569-3574.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.9
, pp. 3569-3574
-
-
Brennan, G.1
Kozyrev, Y.2
Hu, S.L.3
-
28
-
-
0032973455
-
In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
-
Brodie S.J., Lewinsohn D.A., Patterson B.K., Jiyamapa D., Krieger J., Corey L., Greenberg P.D., Riddell S.R. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 1999, 5(1):34-41.
-
(1999)
Nat. Med.
, vol.5
, Issue.1
, pp. 34-41
-
-
Brodie, S.J.1
Lewinsohn, D.A.2
Patterson, B.K.3
Jiyamapa, D.4
Krieger, J.5
Corey, L.6
Greenberg, P.D.7
Riddell, S.R.8
-
29
-
-
0034028070
-
HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
-
Brodie S.J., Patterson B.K., Lewinsohn D.A., Diem K., Spach D., Greenberg P.D., Riddell S.R., Corey L. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J. Clin. Invest. 2000, 105(10):1407-1417.
-
(2000)
J. Clin. Invest.
, vol.105
, Issue.10
, pp. 1407-1417
-
-
Brodie, S.J.1
Patterson, B.K.2
Lewinsohn, D.A.3
Diem, K.4
Spach, D.5
Greenberg, P.D.6
Riddell, S.R.7
Corey, L.8
-
30
-
-
77956829730
-
P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages
-
Burdick R., Smith J.L., Chaipan C., Friew Y., Chen J., Venkatachari N.J., Delviks-Frankenberry K.A., Hu W.S., Pathak V.K. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J. Virol. 2010, 84(19):10241-10253.
-
(2010)
J. Virol.
, vol.84
, Issue.19
, pp. 10241-10253
-
-
Burdick, R.1
Smith, J.L.2
Chaipan, C.3
Friew, Y.4
Chen, J.5
Venkatachari, N.J.6
Delviks-Frankenberry, K.A.7
Hu, W.S.8
Pathak, V.K.9
-
31
-
-
0242300128
-
Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression
-
Butticaz C., Ciuffi A., Munoz M., Thomas J., Bridge A., Pebernard S., Iggo R., Meylan P., Telenti A. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir. Ther. 2003, 8(5):373-377.
-
(2003)
Antivir. Ther.
, vol.8
, Issue.5
, pp. 373-377
-
-
Butticaz, C.1
Ciuffi, A.2
Munoz, M.3
Thomas, J.4
Bridge, A.5
Pebernard, S.6
Iggo, R.7
Meylan, P.8
Telenti, A.9
-
32
-
-
0033811703
-
Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts
-
Cagnon L., Rossi J.J. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts. Antisense Nucleic Acid Drug Dev. 2000, 10(4):251-261.
-
(2000)
Antisense Nucleic Acid Drug Dev.
, vol.10
, Issue.4
, pp. 251-261
-
-
Cagnon, L.1
Rossi, J.J.2
-
33
-
-
0036839458
-
Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference
-
Capodici J., Kariko K., Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 2002, 169(9):5196-5201.
-
(2002)
J. Immunol.
, vol.169
, Issue.9
, pp. 5196-5201
-
-
Capodici, J.1
Kariko, K.2
Weissman, D.3
-
34
-
-
70449427834
-
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy
-
Cartier N., Hacein-Bey-Abina S., Bartholomae C.C., Veres G., Schmidt M., Kutschera I., Vidaud M., Abel U., Dal-Cortivo L., Caccavelli L., Mahlaoui N., Kiermer V., Mittelstaedt D., Bellesme C., Lahlou N., Lefrere F., Blanche S., Audit M., Payen E., Leboulch P., l'Homme B., Bougneres P., Von Kalle C., Fischer A., Cavazzana-Calvo M., Aubourg P. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326(5954):818-823.
-
(2009)
Science
, vol.326
, Issue.5954
, pp. 818-823
-
-
Cartier, N.1
Hacein-Bey-Abina, S.2
Bartholomae, C.C.3
Veres, G.4
Schmidt, M.5
Kutschera, I.6
Vidaud, M.7
Abel, U.8
Dal-Cortivo, L.9
Caccavelli, L.10
Mahlaoui, N.11
Kiermer, V.12
Mittelstaedt, D.13
Bellesme, C.14
Lahlou, N.15
Lefrere, F.16
Blanche, S.17
Audit, M.18
Payen, E.19
Leboulch, P.20
l'Homme, B.21
Bougneres, P.22
Von Kalle, C.23
Fischer, A.24
Cavazzana-Calvo, M.25
Aubourg, P.26
more..
-
35
-
-
0034724857
-
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
-
Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., Bousso P., Deist F.L., Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288(5466):669-672.
-
(2000)
Science
, vol.288
, Issue.5466
, pp. 669-672
-
-
Cavazzana-Calvo, M.1
Hacein-Bey, S.2
de Saint Basile, G.3
Gross, F.4
Yvon, E.5
Nusbaum, P.6
Selz, F.7
Hue, C.8
Certain, S.9
Casanova, J.L.10
Bousso, P.11
Deist, F.L.12
Fischer, A.13
-
36
-
-
77956928344
-
Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia
-
Cavazzana-Calvo M., Payen E., Negre O., Wang G., Hehir K., Fusil F., Down J., Denaro M., Brady T., Westerman K., Cavallesco R., Gillet-Legrand B., Caccavelli L., Sgarra R., Maouche-Chretien L., Bernaudin F., Girot R., Dorazio R., Mulder G.J., Polack A., Bank A., Soulier J., Larghero J., Kabbara N., Dalle B., Gourmel B., Socie G., Chretien S., Cartier N., Aubourg P., Fischer A., Cornetta K., Galacteros F., Beuzard Y., Gluckman E., Bushman F., Hacein-Bey-Abina S., Leboulch P. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010, 467(7313):318-322.
-
(2010)
Nature
, vol.467
, Issue.7313
, pp. 318-322
-
-
Cavazzana-Calvo, M.1
Payen, E.2
Negre, O.3
Wang, G.4
Hehir, K.5
Fusil, F.6
Down, J.7
Denaro, M.8
Brady, T.9
Westerman, K.10
Cavallesco, R.11
Gillet-Legrand, B.12
Caccavelli, L.13
Sgarra, R.14
Maouche-Chretien, L.15
Bernaudin, F.16
Girot, R.17
Dorazio, R.18
Mulder, G.J.19
Polack, A.20
Bank, A.21
Soulier, J.22
Larghero, J.23
Kabbara, N.24
Dalle, B.25
Gourmel, B.26
Socie, G.27
Chretien, S.28
Cartier, N.29
Aubourg, P.30
Fischer, A.31
Cornetta, K.32
Galacteros, F.33
Beuzard, Y.34
Gluckman, E.35
Bushman, F.36
Hacein-Bey-Abina, S.37
Leboulch, P.38
more..
-
37
-
-
0033613342
-
Re-emergence of HIV after stopping therapy
-
Chun T.W., Davey R.T., Engel D., Lane H.C., Fauci A.S. Re-emergence of HIV after stopping therapy. Nature 1999, 401(6756):874-875.
-
(1999)
Nature
, vol.401
, Issue.6756
, pp. 874-875
-
-
Chun, T.W.1
Davey, R.T.2
Engel, D.3
Lane, H.C.4
Fauci, A.S.5
-
38
-
-
0033168142
-
Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity
-
Clay T.M., Custer M.C., Sachs J., Hwu P., Rosenberg S.A., Nishimura M.I. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 1999, 163(1):507-513.
-
(1999)
J. Immunol.
, vol.163
, Issue.1
, pp. 507-513
-
-
Clay, T.M.1
Custer, M.C.2
Sachs, J.3
Hwu, P.4
Rosenberg, S.A.5
Nishimura, M.I.6
-
39
-
-
0033887418
-
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
-
Cooper L.J., Kalos M., Lewinsohn D.A., Riddell S.R., Greenberg P.D. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J. Virol. 2000, 74(17):8207-8212.
-
(2000)
J. Virol.
, vol.74
, Issue.17
, pp. 8207-8212
-
-
Cooper, L.J.1
Kalos, M.2
Lewinsohn, D.A.3
Riddell, S.R.4
Greenberg, P.D.5
-
40
-
-
0001633495
-
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
-
Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273(5283):1856-1862.
-
(1996)
Science
, vol.273
, Issue.5283
, pp. 1856-1862
-
-
Dean, M.1
Carrington, M.2
Winkler, C.3
Huttley, G.A.4
Smith, M.W.5
Allikmets, R.6
Goedert, J.J.7
Buchbinder, S.P.8
Vittinghoff, E.9
Gomperts, E.10
Donfield, S.11
Vlahov, D.12
Kaslow, R.13
Saah, A.14
Rinaldo, C.15
Detels, R.16
O'Brien, S.J.17
-
41
-
-
79951769839
-
HIV Infection, Inflammation, Immunosenescence, and Aging
-
Deeks S.G. HIV Infection, Inflammation, Immunosenescence, and Aging. Annu. Rev. Med. 2010, http://www.annualreviews.org/catalog/pubdates.aspx.
-
(2010)
Annu. Rev. Med.
-
-
Deeks, S.G.1
-
42
-
-
0035989039
-
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy
-
Deeks S.G., Wagner B., Anton P.A., Mitsuyasu R.T., Scadden D.T., Huang C., Macken C., Richman D.D., Christopherson C., June C.H., Lazar R., Broad D.F., Jalali S., Hege K.M. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol. Ther. 2002, 5(6):788-797.
-
(2002)
Mol. Ther.
, vol.5
, Issue.6
, pp. 788-797
-
-
Deeks, S.G.1
Wagner, B.2
Anton, P.A.3
Mitsuyasu, R.T.4
Scadden, D.T.5
Huang, C.6
Macken, C.7
Richman, D.D.8
Christopherson, C.9
June, C.H.10
Lazar, R.11
Broad, D.F.12
Jalali, S.13
Hege, K.M.14
-
43
-
-
35349030307
-
Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials
-
DiGiusto D.L., Cooper L.J. Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials. Cytotherapy 2007, 9(7):613-629.
-
(2007)
Cytotherapy
, vol.9
, Issue.7
, pp. 613-629
-
-
DiGiusto, D.L.1
Cooper, L.J.2
-
44
-
-
77955608799
-
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma
-
DiGiusto D.L., Krishnan A., Li L., Li H., Li S., Rao A., Mi S., Yam P., Stinson S., Kalos M., Alvarnas J., Lacey S.F., Yee J.K., Li M., Couture L., Hsu D., Forman S.J., Rossi J.J., Zaia J.A. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med. 2010, 2(36):36ra43.
-
(2010)
Sci. Transl. Med.
, vol.2
, Issue.36
-
-
DiGiusto, D.L.1
Krishnan, A.2
Li, L.3
Li, H.4
Li, S.5
Rao, A.6
Mi, S.7
Yam, P.8
Stinson, S.9
Kalos, M.10
Alvarnas, J.11
Lacey, S.F.12
Yee, J.K.13
Li, M.14
Couture, L.15
Hsu, D.16
Forman, S.J.17
Rossi, J.J.18
Zaia, J.A.19
-
45
-
-
67249121143
-
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
-
Dinoso J.B., Kim S.Y., Wiegand A.M., Palmer S.E., Gange S.J., Cranmer L., O'Shea A., Callender M., Spivak A., Brennan T., Kearney M.F., Proschan M.A., Mican J.M., Rehm C.A., Coffin J.M., Mellors J.W., Siliciano R.F., Maldarelli F. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 2009, 106(23):9403-9408.
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, Issue.23
, pp. 9403-9408
-
-
Dinoso, J.B.1
Kim, S.Y.2
Wiegand, A.M.3
Palmer, S.E.4
Gange, S.J.5
Cranmer, L.6
O'Shea, A.7
Callender, M.8
Spivak, A.9
Brennan, T.10
Kearney, M.F.11
Proschan, M.A.12
Mican, J.M.13
Rehm, C.A.14
Coffin, J.M.15
Mellors, J.W.16
Siliciano, R.F.17
Maldarelli, F.18
-
46
-
-
15844389650
-
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
-
Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381(6584):667-673.
-
(1996)
Nature
, vol.381
, Issue.6584
, pp. 667-673
-
-
Dragic, T.1
Litwin, V.2
Allaway, G.P.3
Martin, S.R.4
Huang, Y.5
Nagashima, K.A.6
Cayanan, C.7
Maddon, P.J.8
Koup, R.A.9
Moore, J.P.10
Paxton, W.A.11
-
47
-
-
9144270207
-
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
-
Egelhofer M., Brandenburg G., Martinius H., Schult-Dietrich P., Melikyan G., Kunert R., Baum C., Choi I., Alexandrov A., von Laer D. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J. Virol. 2004, 78(2):568-575.
-
(2004)
J. Virol.
, vol.78
, Issue.2
, pp. 568-575
-
-
Egelhofer, M.1
Brandenburg, G.2
Martinius, H.3
Schult-Dietrich, P.4
Melikyan, G.5
Kunert, R.6
Baum, C.7
Choi, I.8
Alexandrov, A.9
von Laer, D.10
-
48
-
-
0034715552
-
Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5
-
Feng Y., Leavitt M., Tritz R., Duarte E., Kang D., Mamounas M., Gilles P., Wong-Staal F., Kennedy S., Merson J., Yu M., Barber J.R. Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5. Virology 2000, 276(2):271-278.
-
(2000)
Virology
, vol.276
, Issue.2
, pp. 271-278
-
-
Feng, Y.1
Leavitt, M.2
Tritz, R.3
Duarte, E.4
Kang, D.5
Mamounas, M.6
Gilles, P.7
Wong-Staal, F.8
Kennedy, S.9
Merson, J.10
Yu, M.11
Barber, J.R.12
-
49
-
-
0032545933
-
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
-
Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391(6669):806-811.
-
(1998)
Nature
, vol.391
, Issue.6669
, pp. 806-811
-
-
Fire, A.1
Xu, S.2
Montgomery, M.K.3
Kostas, S.A.4
Driver, S.E.5
Mello, C.C.6
-
50
-
-
77949408184
-
Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity
-
Furtak V., Mulky A., Rawlings S.A., Kozhaya L., Lee K., Kewalramani V.N., Unutmaz D. Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS ONE 2010, 5(2):e9081.
-
(2010)
PLoS ONE
, vol.5
, Issue.2
-
-
Furtak, V.1
Mulky, A.2
Rawlings, S.A.3
Kozhaya, L.4
Lee, K.5
Kewalramani, V.N.6
Unutmaz, D.7
-
51
-
-
33746846198
-
T lineage differentiation from human embryonic stem cells
-
Galic Z., Kitchen S.G., Kacena A., Subramanian A., Burke B., Cortado R., Zack J.A. T lineage differentiation from human embryonic stem cells. Proc. Natl Acad. Sci. USA 2006, 103(31):11742-11747.
-
(2006)
Proc. Natl Acad. Sci. USA
, vol.103
, Issue.31
, pp. 11742-11747
-
-
Galic, Z.1
Kitchen, S.G.2
Kacena, A.3
Subramanian, A.4
Burke, B.5
Cortado, R.6
Zack, J.A.7
-
52
-
-
59849092903
-
Generation of T lineage cells from human embryonic stem cells in a feeder free system
-
Galic Z., Kitchen S.G., Subramanian A., Bristol G., Marsden M.D., Balamurugan A., Kacena A., Yang O., Zack J.A. Generation of T lineage cells from human embryonic stem cells in a feeder free system. Stem Cells 2009, 27(1):100-107.
-
(2009)
Stem Cells
, vol.27
, Issue.1
, pp. 100-107
-
-
Galic, Z.1
Kitchen, S.G.2
Subramanian, A.3
Bristol, G.4
Marsden, M.D.5
Balamurugan, A.6
Kacena, A.7
Yang, O.8
Zack, J.A.9
-
53
-
-
19944421384
-
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
-
Gaspar H.B., Parsley K.L., Howe S., King D., Gilmour K.C., Sinclair J., Brouns G., Schmidt M., Von Kalle C., Barington T., Jakobsen M.A., Christensen H.O., Al Ghonaium A., White H.N., Smith J.L., Levinsky R.J., Ali R.R., Kinnon C., Thrasher A.J. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004, 364(9452):2181-2187.
-
(2004)
Lancet
, vol.364
, Issue.9452
, pp. 2181-2187
-
-
Gaspar, H.B.1
Parsley, K.L.2
Howe, S.3
King, D.4
Gilmour, K.C.5
Sinclair, J.6
Brouns, G.7
Schmidt, M.8
Von Kalle, C.9
Barington, T.10
Jakobsen, M.A.11
Christensen, H.O.12
Al Ghonaium, A.13
White, H.N.14
Smith, J.L.15
Levinsky, R.J.16
Ali, R.R.17
Kinnon, C.18
Thrasher, A.J.19
-
54
-
-
0003799787
-
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides
-
Goodchild J., Agrawal S., Civeira M.P., Sarin P.S., Sun D., Zamecnik P.C. Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc. Natl Acad. Sci. USA 1988, 85(15):5507-5511.
-
(1988)
Proc. Natl Acad. Sci. USA
, vol.85
, Issue.15
, pp. 5507-5511
-
-
Goodchild, J.1
Agrawal, S.2
Civeira, M.P.3
Sarin, P.S.4
Sun, D.5
Zamecnik, P.C.6
-
55
-
-
76349107571
-
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing
-
Govers C., SebestyÈn Z., Coccoris M., Willemsen R.A., Debets R. T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing. Trends Mol. Med. 2010, 16(2):77-87.
-
(2010)
Trends Mol. Med.
, vol.16
, Issue.2
, pp. 77-87
-
-
Govers, C.1
SebestyÈn, Z.2
Coccoris, M.3
Willemsen, R.A.4
Debets, R.5
-
56
-
-
33745299723
-
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
-
Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441(7092):537-541.
-
(2006)
Nature
, vol.441
, Issue.7092
, pp. 537-541
-
-
Grimm, D.1
Streetz, K.L.2
Jopling, C.L.3
Storm, T.A.4
Pandey, K.5
Davis, C.R.6
Marion, P.7
Salazar, F.8
Kay, M.A.9
-
57
-
-
77956355233
-
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver
-
Grimm D., Wang L., Lee J.S., Schurmann N., Gu S., Borner K., Storm T.A., Kay M.A. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J. Clin. Invest. 2010, 120(9):3106-3119.
-
(2010)
J. Clin. Invest.
, vol.120
, Issue.9
, pp. 3106-3119
-
-
Grimm, D.1
Wang, L.2
Lee, J.S.3
Schurmann, N.4
Gu, S.5
Borner, K.6
Storm, T.A.7
Kay, M.A.8
-
58
-
-
67249100279
-
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion
-
Gupta R.K., Hue S., Schaller T., Verschoor E., Pillay D., Towers G.J. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 2009, 5(5):e1000443.
-
(2009)
PLoS Pathog.
, vol.5
, Issue.5
-
-
Gupta, R.K.1
Hue, S.2
Schaller, T.3
Verschoor, E.4
Pillay, D.5
Towers, G.J.6
-
59
-
-
38549096234
-
Shaping and reshaping CD8+ T-cell memory
-
Harty J.T., Badovinac V.P. Shaping and reshaping CD8+ T-cell memory. Nat. Rev. Immunol. 2008, 8(2):107-119.
-
(2008)
Nat. Rev. Immunol.
, vol.8
, Issue.2
, pp. 107-119
-
-
Harty, J.T.1
Badovinac, V.P.2
-
60
-
-
77649221824
-
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
-
Heslop H.E., Slobod K.S., Pule M.A., Hale G.A., Rousseau A., Smith C.A., Bollard C.M., Liu H., Wu M.F., Rochester R.J., Amrolia P.J., Hurwitz J.L., Brenner M.K., Rooney C.M. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 2010, 115(5):925-935.
-
(2010)
Blood
, vol.115
, Issue.5
, pp. 925-935
-
-
Heslop, H.E.1
Slobod, K.S.2
Pule, M.A.3
Hale, G.A.4
Rousseau, A.5
Smith, C.A.6
Bollard, C.M.7
Liu, H.8
Wu, M.F.9
Rochester, R.J.10
Amrolia, P.J.11
Hurwitz, J.L.12
Brenner, M.K.13
Rooney, C.M.14
-
61
-
-
67249131966
-
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers
-
Hessell A.J., Rakasz E.G., Poignard P., Hangartner L., Landucci G., Forthal D.N., Koff W.C., Watkins D.I., Burton D.R. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 2009, 5(5):e1000433.
-
(2009)
PLoS Pathog.
, vol.5
, Issue.5
-
-
Hessell, A.J.1
Rakasz, E.G.2
Poignard, P.3
Hangartner, L.4
Landucci, G.5
Forthal, D.N.6
Koff, W.C.7
Watkins, D.I.8
Burton, D.R.9
-
62
-
-
78751689288
-
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
-
Hinrichs C.S., Borman Z.A., Gattinoni L., Yu Z., Burns W.R., Huang J., Klebanoff C.A., Johnson L.A., Kerkar S.P., Yang S., Muranski P., Palmer D.C., Scott C.D., Morgan R.A., Robbins P.F., Rosenberg S.A., Restifo N.P. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood 2011, 117(3):808-814.
-
(2011)
Blood
, vol.117
, Issue.3
, pp. 808-814
-
-
Hinrichs, C.S.1
Borman, Z.A.2
Gattinoni, L.3
Yu, Z.4
Burns, W.R.5
Huang, J.6
Klebanoff, C.A.7
Johnson, L.A.8
Kerkar, S.P.9
Yang, S.10
Muranski, P.11
Palmer, D.C.12
Scott, C.D.13
Morgan, R.A.14
Robbins, P.F.15
Rosenberg, S.A.16
Restifo, N.P.17
-
63
-
-
52249111614
-
Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA
-
Hofmann C., Harrer T., Kubesch V., Maurer K., Metzner K.J., Eismann K., Bergmann S., Schmitt-Haendle M., Schuler G., Dorrie J., Schaft N. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA. AIDS 2008, 22(13):1577-1582.
-
(2008)
AIDS
, vol.22
, Issue.13
, pp. 1577-1582
-
-
Hofmann, C.1
Harrer, T.2
Kubesch, V.3
Maurer, K.4
Metzner, K.J.5
Eismann, K.6
Bergmann, S.7
Schmitt-Haendle, M.8
Schuler, G.9
Dorrie, J.10
Schaft, N.11
-
64
-
-
33847625391
-
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G
-
Holmes R.K., Koning F.A., Bishop K.N., Malim M.H. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 2007, 282(4):2587-2595.
-
(2007)
J. Biol. Chem.
, vol.282
, Issue.4
, pp. 2587-2595
-
-
Holmes, R.K.1
Koning, F.A.2
Bishop, K.N.3
Malim, M.H.4
-
65
-
-
78650735673
-
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
-
Holt N., Wang J., Kim K., Friedman G., Wang X., Taupin V., Crooks G.M., Kohn D.B., Gregory P.D., Holmes M.C., Cannon P.M. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat. Biotechnol. 2010, 28(8):839-847.
-
(2010)
Nat. Biotechnol.
, vol.28
, Issue.8
, pp. 839-847
-
-
Holt, N.1
Wang, J.2
Kim, K.3
Friedman, G.4
Wang, X.5
Taupin, V.6
Crooks, G.M.7
Kohn, D.B.8
Gregory, P.D.9
Holmes, M.C.10
Cannon, P.M.11
-
66
-
-
84879107855
-
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
-
Huang K.H., Bonsall D., Katzourakis A., Thomson E.C., Fidler S.J., Main J., Muir D., Weber J.N., Frater A.J., Phillips R.E., Pybus O.G., Goulder P.J., McClure M.O., Cooke G.S., Klenerman P. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat. Commun. 2010, 1(7):102.
-
(2010)
Nat. Commun.
, vol.1
, Issue.7
, pp. 102
-
-
Huang, K.H.1
Bonsall, D.2
Katzourakis, A.3
Thomson, E.C.4
Fidler, S.J.5
Main, J.6
Muir, D.7
Weber, J.N.8
Frater, A.J.9
Phillips, R.E.10
Pybus, O.G.11
Goulder, P.J.12
McClure, M.O.13
Cooke, G.S.14
Klenerman, P.15
-
67
-
-
3042735441
-
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load
-
Humeau L.M., Binder G.K., Lu X., Slepushkin V., Merling R., Echeagaray P., Pereira M., Slepushkina T., Barnett S., Dropulic L.K., Carroll R., Levine B.L., June C.H., Dropulic B. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol. Ther. 2004, 9(6):902-913.
-
(2004)
Mol. Ther.
, vol.9
, Issue.6
, pp. 902-913
-
-
Humeau, L.M.1
Binder, G.K.2
Lu, X.3
Slepushkin, V.4
Merling, R.5
Echeagaray, P.6
Pereira, M.7
Slepushkina, T.8
Barnett, S.9
Dropulic, L.K.10
Carroll, R.11
Levine, B.L.12
June, C.H.13
Dropulic, B.14
-
68
-
-
60549090253
-
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation
-
Hutter G., Nowak D., Mossner M., Ganepola S., Mussig A., Allers K., Schneider T., Hofmann J., Kucherer C., Blau O., Blau I.W., Hofmann W.K., Thiel E. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 2009, 360(7):692-698.
-
(2009)
N. Engl. J. Med.
, vol.360
, Issue.7
, pp. 692-698
-
-
Hutter, G.1
Nowak, D.2
Mossner, M.3
Ganepola, S.4
Mussig, A.5
Allers, K.6
Schneider, T.7
Hofmann, J.8
Kucherer, C.9
Blau, O.10
Blau, I.W.11
Hofmann, W.K.12
Thiel, E.13
-
69
-
-
33750324618
-
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
-
Johnson L.A., Heemskerk B., Powell D.J., Cohen C.J., Morgan R.A., Dudley M.E., Robbins P.F., Rosenberg S.A. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J. Immunol. 2006, 177(9):6548-6559.
-
(2006)
J. Immunol.
, vol.177
, Issue.9
, pp. 6548-6559
-
-
Johnson, L.A.1
Heemskerk, B.2
Powell, D.J.3
Cohen, C.J.4
Morgan, R.A.5
Dudley, M.E.6
Robbins, P.F.7
Rosenberg, S.A.8
-
70
-
-
40149106131
-
Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity
-
Joseph A., Zheng J.H., Follenzi A., Dilorenzo T., Sango K., Hyman J., Chen K., Piechocka-Trocha A., Brander C., Hooijberg E., Vignali D.A., Walker B.D., Goldstein H. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity. J. Virol. 2008, 82(6):3078-3089.
-
(2008)
J. Virol.
, vol.82
, Issue.6
, pp. 3078-3089
-
-
Joseph, A.1
Zheng, J.H.2
Follenzi, A.3
Dilorenzo, T.4
Sango, K.5
Hyman, J.6
Chen, K.7
Piechocka-Trocha, A.8
Brander, C.9
Hooijberg, E.10
Vignali, D.A.11
Walker, B.D.12
Goldstein, H.13
-
71
-
-
77953311689
-
Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody
-
Joseph A., Zheng J.H., Chen K., Dutta M., Chen C., Stiegler G., Kunert R., Follenzi A., Goldstein H. Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody. J. Virol. 2010, 84(13):6645-6653.
-
(2010)
J. Virol.
, vol.84
, Issue.13
, pp. 6645-6653
-
-
Joseph, A.1
Zheng, J.H.2
Chen, K.3
Dutta, M.4
Chen, C.5
Stiegler, G.6
Kunert, R.7
Follenzi, A.8
Goldstein, H.9
-
72
-
-
34249868241
-
Adoptive T cell therapy for cancer in the clinic
-
June C.H. Adoptive T cell therapy for cancer in the clinic. J. Clin. Invest. 2007, 117(6):1466-1476.
-
(2007)
J. Clin. Invest.
, vol.117
, Issue.6
, pp. 1466-1476
-
-
June, C.H.1
-
73
-
-
70349438847
-
Engineering lymphocyte subsets: tools, trials and tribulations
-
June C.H., Blazar B.R., Riley J.L. Engineering lymphocyte subsets: tools, trials and tribulations. Nat. Rev. Immunol. 2009, 9(10):704-716.
-
(2009)
Nat. Rev. Immunol.
, vol.9
, Issue.10
, pp. 704-716
-
-
June, C.H.1
Blazar, B.R.2
Riley, J.L.3
-
74
-
-
79952191792
-
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells
-
doi:10.1038/mt.2010.269
-
Kambal A., Mitchell G., Cary W., Gruenloh W., Jung Y., Kalomoiris S., Nacey C., McGee J., Lindsey M., Fury B., Bauer G., Nolta J.A., Anderson J.S. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Mol. Ther. 2010, doi:10.1038/mt.2010.269.
-
(2010)
Mol. Ther.
-
-
Kambal, A.1
Mitchell, G.2
Cary, W.3
Gruenloh, W.4
Jung, Y.5
Kalomoiris, S.6
Nacey, C.7
McGee, J.8
Lindsey, M.9
Fury, B.10
Bauer, G.11
Nolta, J.A.12
Anderson, J.S.13
-
75
-
-
60849098427
-
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes
-
Kaneko S., Mastaglio S., Bondanza A., Ponzoni M., Sanvito F., Aldrighetti L., Radrizzani M., La Seta-Catamancio S., Provasi E., Mondino A., Nagasawa T., Fleischhauer K., Russo V., Traversari C., Ciceri F., Bordignon C., Bonini C. IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood 2009, 113(5):1006-1015.
-
(2009)
Blood
, vol.113
, Issue.5
, pp. 1006-1015
-
-
Kaneko, S.1
Mastaglio, S.2
Bondanza, A.3
Ponzoni, M.4
Sanvito, F.5
Aldrighetti, L.6
Radrizzani, M.7
La Seta-Catamancio, S.8
Provasi, E.9
Mondino, A.10
Nagasawa, T.11
Fleischhauer, K.12
Russo, V.13
Traversari, C.14
Ciceri, F.15
Bordignon, C.16
Bonini, C.17
-
76
-
-
0036802425
-
Gene therapy-based treatment for HIV-positive patients with malignancies
-
Kang E.M., De Witte M., Malech H., Morgan R.A., Carter C., Leitman S.F., Childs R., Barrett A.J., Little R., Tisdale J.F. Gene therapy-based treatment for HIV-positive patients with malignancies. J. Hematother. Stem Cell Res. 2002, 11(5):809-816.
-
(2002)
J. Hematother. Stem Cell Res.
, vol.11
, Issue.5
, pp. 809-816
-
-
Kang, E.M.1
De Witte, M.2
Malech, H.3
Morgan, R.A.4
Carter, C.5
Leitman, S.F.6
Childs, R.7
Barrett, A.J.8
Little, R.9
Tisdale, J.F.10
-
77
-
-
74349091890
-
Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo
-
Kiem H.P., Wu R.A., Sun G., von Laer D., Rossi J.J., Trobridge G.D. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Ther. 2009, 17(1):37-49.
-
(2009)
Gene Ther.
, vol.17
, Issue.1
, pp. 37-49
-
-
Kiem, H.P.1
Wu, R.A.2
Sun, G.3
von Laer, D.4
Rossi, J.J.5
Trobridge, G.D.6
-
78
-
-
74349091890
-
Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo
-
Kiem H.P., Wu R.A., Sun G., von Laer D., Rossi J.J., Trobridge G.D. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Ther. 2010, 17(1):37-49.
-
(2010)
Gene Ther.
, vol.17
, Issue.1
, pp. 37-49
-
-
Kiem, H.P.1
Wu, R.A.2
Sun, G.3
von Laer, D.4
Rossi, J.J.5
Trobridge, G.D.6
-
79
-
-
76349095131
-
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice
-
Kim S.S., Peer D., Kumar P., Subramanya S., Wu H., Asthana D., Habiro K., Yang Y.G., Manjunath N., Shimaoka M., Shankar P. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol. Ther. 2010, 18(2):370-376.
-
(2010)
Mol. Ther.
, vol.18
, Issue.2
, pp. 370-376
-
-
Kim, S.S.1
Peer, D.2
Kumar, P.3
Subramanya, S.4
Wu, H.5
Asthana, D.6
Habiro, K.7
Yang, Y.G.8
Manjunath, N.9
Shimaoka, M.10
Shankar, P.11
-
80
-
-
77957868380
-
Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection
-
Kimpel J., Braun S.E., Qiu G., Wong F.E., Conolle M., Schmitz J.E., Brendel C., Humeau L.M., Dropulic B., Rossi J.J., Berger A., von Laer D., Johnson R.P. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS ONE 2010, 5(8):e12357.
-
(2010)
PLoS ONE
, vol.5
, Issue.8
-
-
Kimpel, J.1
Braun, S.E.2
Qiu, G.3
Wong, F.E.4
Conolle, M.5
Schmitz, J.E.6
Brendel, C.7
Humeau, L.M.8
Dropulic, B.9
Rossi, J.J.10
Berger, A.11
von Laer, D.12
Johnson, R.P.13
-
81
-
-
77949515006
-
Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice
-
Kitchen S.G., Bennett M., Galic Z., Kim J., Xu Q., Young A., Lieberman A., Joseph A., Goldstein H., Ng H., Yang O., Zack J.A. Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. PLoS ONE 2009, 4(12):e8208.
-
(2009)
PLoS ONE
, vol.4
, Issue.12
-
-
Kitchen, S.G.1
Bennett, M.2
Galic, Z.3
Kim, J.4
Xu, Q.5
Young, A.6
Lieberman, A.7
Joseph, A.8
Goldstein, H.9
Ng, H.10
Yang, O.11
Zack, J.A.12
-
82
-
-
0033168686
-
A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children
-
Kohn D.B., Bauer G., Rice C.R., Rothschild J.C., Carbonaro D.A., Valdez P., Hao Q., Zhou C., Bahner I., Kearns K., Brody K., Fox S., Haden E., Wilson K., Salata C., Dolan C., Wetter C., Aguilar-Cordova E., Church J. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 1999, 94(1):368-371.
-
(1999)
Blood
, vol.94
, Issue.1
, pp. 368-371
-
-
Kohn, D.B.1
Bauer, G.2
Rice, C.R.3
Rothschild, J.C.4
Carbonaro, D.A.5
Valdez, P.6
Hao, Q.7
Zhou, C.8
Bahner, I.9
Kearns, K.10
Brody, K.11
Fox, S.12
Haden, E.13
Wilson, K.14
Salata, C.15
Dolan, C.16
Wetter, C.17
Aguilar-Cordova, E.18
Church, J.19
-
83
-
-
38949206356
-
Passive immunization as tool to identify protective HIV-1 Env epitopes
-
Kramer V.G., Siddappa N.B., Ruprecht R.M. Passive immunization as tool to identify protective HIV-1 Env epitopes. Curr. HIV Res. 2007, 5(6):642-655.
-
(2007)
Curr. HIV Res.
, vol.5
, Issue.6
, pp. 642-655
-
-
Kramer, V.G.1
Siddappa, N.B.2
Ruprecht, R.M.3
-
84
-
-
10744229122
-
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults
-
Lalezari J.P., DeJesus E., Northfelt D.W., Richmond G., Wolfe P., Haubrich R., Henry D., Powderly W., Becker S., Thompson M., Valentine F., Wright D., Carlson M., Riddler S., Haas F.F., DeMasi R., Sista P.R., Salgo M., Delehanty J. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. Antivir. Ther. 2003, 8(4):279-287.
-
(2003)
Antivir. Ther.
, vol.8
, Issue.4
, pp. 279-287
-
-
Lalezari, J.P.1
DeJesus, E.2
Northfelt, D.W.3
Richmond, G.4
Wolfe, P.5
Haubrich, R.6
Henry, D.7
Powderly, W.8
Becker, S.9
Thompson, M.10
Valentine, F.11
Wright, D.12
Carlson, M.13
Riddler, S.14
Haas, F.F.15
DeMasi, R.16
Sista, P.R.17
Salgo, M.18
Delehanty, J.19
-
85
-
-
0036256430
-
Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells
-
Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 2002, 20(5):500-505.
-
(2002)
Nat. Biotechnol.
, vol.20
, Issue.5
, pp. 500-505
-
-
Lee, N.S.1
Dohjima, T.2
Bauer, G.3
Li, H.4
Li, M.J.5
Ehsani, A.6
Salvaterra, P.7
Rossi, J.8
-
86
-
-
77749342887
-
Flexible use of nuclear import pathways by HIV-1
-
Lee K., Ambrose Z., Martin T.D., Oztop I., Mulky A., Julias J.G., Vandegraaff N., Baumann J.G., Wang R., Yuen W., Takemura T., Shelton K., Taniuchi I., Li Y., Sodroski J., Littman D.R., Coffin J.M., Hughes S.H., Unutmaz D., Engelman A., KewalRamani V.N. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7(3):221-233.
-
(2010)
Cell Host Microbe
, vol.7
, Issue.3
, pp. 221-233
-
-
Lee, K.1
Ambrose, Z.2
Martin, T.D.3
Oztop, I.4
Mulky, A.5
Julias, J.G.6
Vandegraaff, N.7
Baumann, J.G.8
Wang, R.9
Yuen, W.10
Takemura, T.11
Shelton, K.12
Taniuchi, I.13
Li, Y.14
Sodroski, J.15
Littman, D.R.16
Coffin, J.M.17
Hughes, S.H.18
Unutmaz, D.19
Engelman, A.20
KewalRamani, V.N.21
more..
-
87
-
-
33751251058
-
Gene transfer in humans using a conditionally replicating lentiviral vector
-
Levine B.L., Humeau L.M., Boyer J., MacGregor R.R., Rebello T., Lu X., Binder G.K., Slepushkin V., Lemiale F., Mascola J.R., Bushman F.D., Dropulic B., June C.H. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl Acad. Sci. USA 2006, 103(46):17372-17377.
-
(2006)
Proc. Natl Acad. Sci. USA
, vol.103
, Issue.46
, pp. 17372-17377
-
-
Levine, B.L.1
Humeau, L.M.2
Boyer, J.3
MacGregor, R.R.4
Rebello, T.5
Lu, X.6
Binder, G.K.7
Slepushkin, V.8
Lemiale, F.9
Mascola, J.R.10
Bushman, F.D.11
Dropulic, B.12
June, C.H.13
-
88
-
-
10744228940
-
Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs
-
Li M.J., Bauer G., Michienzi A., Yee J.K., Lee N.S., Kim J., Li S., Castanotto D., Zaia J., Rossi J.J. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol. Ther. 2003, 8(2):196-206.
-
(2003)
Mol. Ther.
, vol.8
, Issue.2
, pp. 196-206
-
-
Li, M.J.1
Bauer, G.2
Michienzi, A.3
Yee, J.K.4
Lee, N.S.5
Kim, J.6
Li, S.7
Castanotto, D.8
Zaia, J.9
Rossi, J.J.10
-
89
-
-
27744605569
-
Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy
-
Li M.J., Kim J., Li S., Zaia J., Yee J.K., Anderson J., Akkina R., Rossi J.J. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol. Ther. 2005, 12(5):900-909.
-
(2005)
Mol. Ther.
, vol.12
, Issue.5
, pp. 900-909
-
-
Li, M.J.1
Kim, J.2
Li, S.3
Zaia, J.4
Yee, J.K.5
Anderson, J.6
Akkina, R.7
Rossi, J.J.8
-
90
-
-
33745800238
-
Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection
-
Li Y., Li X., Stremlau M., Lee M., Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 2006, 80(14):6738-6744.
-
(2006)
J. Virol.
, vol.80
, Issue.14
, pp. 6738-6744
-
-
Li, Y.1
Li, X.2
Stremlau, M.3
Lee, M.4
Sodroski, J.5
-
91
-
-
77349124962
-
Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction
-
Liang M., Kamata M., Chen K.N., Pariente N., An D.S., Chen I.S. Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction. J. Gene Med. 2010, 12(3):255-265.
-
(2010)
J. Gene Med.
, vol.12
, Issue.3
, pp. 255-265
-
-
Liang, M.1
Kamata, M.2
Chen, K.N.3
Pariente, N.4
An, D.S.5
Chen, I.S.6
-
92
-
-
0030854210
-
Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients
-
Lieberman J., Skolnik P.R., Parkerson G.R., Fabry J.A., Landry B., Bethel J., Kagan J. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood 1997, 90(6):2196-2206.
-
(1997)
Blood
, vol.90
, Issue.6
, pp. 2196-2206
-
-
Lieberman, J.1
Skolnik, P.R.2
Parkerson, G.R.3
Fabry, J.A.4
Landry, B.5
Bethel, J.6
Kagan, J.7
-
93
-
-
15844388931
-
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
-
Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86(3):367-377.
-
(1996)
Cell
, vol.86
, Issue.3
, pp. 367-377
-
-
Liu, R.1
Paxton, W.A.2
Choe, S.3
Ceradini, D.4
Martin, S.R.5
Horuk, R.6
MacDonald, M.E.7
Stuhlmann, H.8
Koup, R.A.9
Landau, N.R.10
-
94
-
-
35348890932
-
Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters
-
Lo H.L., Chang T., Yam P., Marcovecchio P.M., Li S., Zaia J.A., Yee J.K. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene Ther. 2007, 14(21):1503-1512.
-
(2007)
Gene Ther.
, vol.14
, Issue.21
, pp. 1503-1512
-
-
Lo, H.L.1
Chang, T.2
Yam, P.3
Marcovecchio, P.M.4
Li, S.5
Zaia, J.A.6
Yee, J.K.7
-
95
-
-
41349090105
-
Generation of human induced pluripotent stem cells from dermal fibroblasts
-
Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 2008, 105(8):2883-2888.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.8
, pp. 2883-2888
-
-
Lowry, W.E.1
Richter, L.2
Yachechko, R.3
Pyle, A.D.4
Tchieu, J.5
Sridharan, R.6
Clark, A.T.7
Plath, K.8
-
96
-
-
0031424990
-
Frequencies of the CC chemokine receptor 5 delta 32 allele in various populations of defined racial background
-
Lucotte G. Frequencies of the CC chemokine receptor 5 delta 32 allele in various populations of defined racial background. Biomed. Pharmacother. 1997, 51(10):469-473.
-
(1997)
Biomed. Pharmacother.
, vol.51
, Issue.10
, pp. 469-473
-
-
Lucotte, G.1
-
97
-
-
61849122809
-
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes
-
Luo X.M., Maarschalk E., O'Connell R.M., Wang P., Yang L., Baltimore D. Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood 2009, 113(7):1422-1431.
-
(2009)
Blood
, vol.113
, Issue.7
, pp. 1422-1431
-
-
Luo, X.M.1
Maarschalk, E.2
O'Connell, R.M.3
Wang, P.4
Yang, L.5
Baltimore, D.6
-
98
-
-
0033951746
-
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
-
Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 2000, 6(2):207-210.
-
(2000)
Nat. Med.
, vol.6
, Issue.2
, pp. 207-210
-
-
Mascola, J.R.1
Stiegler, G.2
VanCott, T.C.3
Katinger, H.4
Carpenter, C.B.5
Hanson, C.E.6
Beary, H.7
Hayes, D.8
Frankel, S.S.9
Birx, D.L.10
Lewis, M.G.11
-
99
-
-
77958490167
-
Induction of immunity to human immunodeficiency virus type-1 by vaccination
-
McElrath M.J., Haynes B.F. Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 2010, 33(4):542-554.
-
(2010)
Immunity
, vol.33
, Issue.4
, pp. 542-554
-
-
McElrath, M.J.1
Haynes, B.F.2
-
100
-
-
35148864699
-
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection
-
Mehandru S., Vcelar B., Wrin T., Stiegler G., Joos B., Mohri H., Boden D., Galovich J., Tenner-Racz K., Racz P., Carrington M., Petropoulos C., Katinger H., Markowitz M. Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. J. Virol. 2007, 81(20):11016-11031.
-
(2007)
J. Virol.
, vol.81
, Issue.20
, pp. 11016-11031
-
-
Mehandru, S.1
Vcelar, B.2
Wrin, T.3
Stiegler, G.4
Joos, B.5
Mohri, H.6
Boden, D.7
Galovich, J.8
Tenner-Racz, K.9
Racz, P.10
Carrington, M.11
Petropoulos, C.12
Katinger, H.13
Markowitz, M.14
-
101
-
-
0033542388
-
Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies
-
Mhashilkar A.M., LaVecchio J., Eberhardt B., Porter-Brooks J., Boisot S., Dove J.H., Pumphrey C., Li X., Weissmahr R.N., Ring D.B., Ramstedt U., Marasco W.A. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Hum. Gene Ther. 1999, 10(9):1453-1467.
-
(1999)
Hum. Gene Ther.
, vol.10
, Issue.9
, pp. 1453-1467
-
-
Mhashilkar, A.M.1
LaVecchio, J.2
Eberhardt, B.3
Porter-Brooks, J.4
Boisot, S.5
Dove, J.H.6
Pumphrey, C.7
Li, X.8
Weissmahr, R.N.9
Ring, D.B.10
Ramstedt, U.11
Marasco, W.A.12
-
102
-
-
33749434105
-
Engineered T cell receptors and their potential in molecular medicine
-
Miles J.J., Silins S.L., Burrows S.R. Engineered T cell receptors and their potential in molecular medicine. Curr. Med. Chem. 2006, 13(23):2725-2736.
-
(2006)
Curr. Med. Chem.
, vol.13
, Issue.23
, pp. 2725-2736
-
-
Miles, J.J.1
Silins, S.L.2
Burrows, S.R.3
-
103
-
-
0034254611
-
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects
-
Mitsuyasu R.T., Anton P.A., Deeks S.G., Scadden D.T., Connick E., Downs M.T., Bakker A., Roberts M.R., June C.H., Jalali S., Lin A.A., Pennathur-Das R., Hege K.M. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. Blood 2000, 96(3):785-793.
-
(2000)
Blood
, vol.96
, Issue.3
, pp. 785-793
-
-
Mitsuyasu, R.T.1
Anton, P.A.2
Deeks, S.G.3
Scadden, D.T.4
Connick, E.5
Downs, M.T.6
Bakker, A.7
Roberts, M.R.8
June, C.H.9
Jalali, S.10
Lin, A.A.11
Pennathur-Das, R.12
Hege, K.M.13
-
104
-
-
62049083710
-
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
-
Mitsuyasu R.T., Merigan T.C., Carr A., Zack J.A., Winters M.A., Workman C., Bloch M., Lalezari J., Becker S., Thornton L., Akil B., Khanlou H., Finlayson R., McFarlane R., Smith D.E., Garsia R., Ma D., Law M., Murray J.M., von Kalle C., Ely J.A., Patino S.M., Knop A.E., Wong P., Todd A.V., Haughton M., Fuery C., Macpherson J.L., Symonds G.P., Evans L.A., Pond S.M., Cooper D.A. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat. Med. 2009, 15(3):285-292.
-
(2009)
Nat. Med.
, vol.15
, Issue.3
, pp. 285-292
-
-
Mitsuyasu, R.T.1
Merigan, T.C.2
Carr, A.3
Zack, J.A.4
Winters, M.A.5
Workman, C.6
Bloch, M.7
Lalezari, J.8
Becker, S.9
Thornton, L.10
Akil, B.11
Khanlou, H.12
Finlayson, R.13
McFarlane, R.14
Smith, D.E.15
Garsia, R.16
Ma, D.17
Law, M.18
Murray, J.M.19
von Kalle, C.20
Ely, J.A.21
Patino, S.M.22
Knop, A.E.23
Wong, P.24
Todd, A.V.25
Haughton, M.26
Fuery, C.27
Macpherson, J.L.28
Symonds, G.P.29
Evans, L.A.30
Pond, S.M.31
Cooper, D.A.32
more..
-
105
-
-
0042834246
-
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
-
Morgan R.A., Dudley M.E., Yu Y.Y., Zheng Z., Robbins P.F., Theoret M.R., Wunderlich J.R., Hughes M.S., Restifo N.P., Rosenberg S.A. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J. Immunol. 2003, 171(6):3287-3295.
-
(2003)
J. Immunol.
, vol.171
, Issue.6
, pp. 3287-3295
-
-
Morgan, R.A.1
Dudley, M.E.2
Yu, Y.Y.3
Zheng, Z.4
Robbins, P.F.5
Theoret, M.R.6
Wunderlich, J.R.7
Hughes, M.S.8
Restifo, N.P.9
Rosenberg, S.A.10
-
106
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., Royal R.E., Topalian S.L., Kammula U.S., Restifo N.P., Zheng Z., Nahvi A., de Vries C.R., Rogers-Freezer L.J., Mavroukakis S.A., Rosenberg S.A. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314(5796):126-129.
-
(2006)
Science
, vol.314
, Issue.5796
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
Hughes, M.S.4
Yang, J.C.5
Sherry, R.M.6
Royal, R.E.7
Topalian, S.L.8
Kammula, U.S.9
Restifo, N.P.10
Zheng, Z.11
Nahvi, A.12
de Vries, C.R.13
Rogers-Freezer, L.J.14
Mavroukakis, S.A.15
Rosenberg, S.A.16
-
107
-
-
77957981209
-
Adoptive cell therapy: genetic modification to redirect effector cell specificity
-
Morgan R.A., Dudley M.E., Rosenberg S.A. Adoptive cell therapy: genetic modification to redirect effector cell specificity. Cancer J. 2010, 16(4):336-341.
-
(2010)
Cancer J.
, vol.16
, Issue.4
, pp. 336-341
-
-
Morgan, R.A.1
Dudley, M.E.2
Rosenberg, S.A.3
-
108
-
-
0031874343
-
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
-
Mummidi S., Ahuja S.S., Gonzalez E., Anderson S.A., Santiago E.N., Stephan K.T., Craig F.E., O'Connell P., Tryon V., Clark R.A., Dolan M.J., Ahuja S.K. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med. 1998, 4(7):786-793.
-
(1998)
Nat. Med.
, vol.4
, Issue.7
, pp. 786-793
-
-
Mummidi, S.1
Ahuja, S.S.2
Gonzalez, E.3
Anderson, S.A.4
Santiago, E.N.5
Stephan, K.T.6
Craig, F.E.7
O'Connell, P.8
Tryon, V.9
Clark, R.A.10
Dolan, M.J.11
Ahuja, S.K.12
-
109
-
-
70349655695
-
Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components
-
Neagu M.R., Ziegler P., Pertel T., Strambio-De-Castillia C., Grutter C., Martinetti G., Mazzucchelli L., Grutter M., Manz M.G., Luban J. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J. Clin. Invest. 2009, 119(10):3035-3047.
-
(2009)
J. Clin. Invest.
, vol.119
, Issue.10
, pp. 3035-3047
-
-
Neagu, M.R.1
Ziegler, P.2
Pertel, T.3
Strambio-De-Castillia, C.4
Grutter, C.5
Martinetti, G.6
Mazzucchelli, L.7
Grutter, M.8
Manz, M.G.9
Luban, J.10
-
110
-
-
38549095979
-
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
-
Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451(7177):425-430.
-
(2008)
Nature
, vol.451
, Issue.7177
, pp. 425-430
-
-
Neil, S.J.1
Zang, T.2
Bieniasz, P.D.3
-
111
-
-
40349106167
-
Evolution of a TRIM5-CypA splice isoform in old world monkeys
-
Newman R.M., Hall L., Kirmaier A., Pozzi L.A., Pery E., Farzan M., O'Neil S.P., Johnson W. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog. 2008, 4(2):e1000003.
-
(2008)
PLoS Pathog.
, vol.4
, Issue.2
-
-
Newman, R.M.1
Hall, L.2
Kirmaier, A.3
Pozzi, L.A.4
Pery, E.5
Farzan, M.6
O'Neil, S.P.7
Johnson, W.8
-
112
-
-
77957820631
-
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
-
Ng C.T., Jaworski J.P., Jayaraman P., Sutton W.F., Delio P., Kuller L., Anderson D., Landucci G., Richardson B.A., Burton D.R., Forthal D.N., Haigwood N.L. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat. Med. 2010, 16(10):1117-1119.
-
(2010)
Nat. Med.
, vol.16
, Issue.10
, pp. 1117-1119
-
-
Ng, C.T.1
Jaworski, J.P.2
Jayaraman, P.3
Sutton, W.F.4
Delio, P.5
Kuller, L.6
Anderson, D.7
Landucci, G.8
Richardson, B.A.9
Burton, D.R.10
Forthal, D.N.11
Haigwood, N.L.12
-
113
-
-
0036066508
-
SiRNA-directed inhibition of HIV-1 infection
-
Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 2002, 8(7):681-686.
-
(2002)
Nat. Med.
, vol.8
, Issue.7
, pp. 681-686
-
-
Novina, C.D.1
Murray, M.F.2
Dykxhoorn, D.M.3
Beresford, P.J.4
Riess, J.5
Lee, S.K.6
Collman, R.G.7
Lieberman, J.8
Shankar, P.9
Sharp, P.A.10
-
114
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
-
Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., Holmberg S.D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med. 1998, 338(13):853-860.
-
(1998)
N. Engl. J. Med.
, vol.338
, Issue.13
, pp. 853-860
-
-
Palella, F.J.1
Delaney, K.M.2
Moorman, A.C.3
Loveless, M.O.4
Fuhrer, J.5
Satten, G.A.6
Aschman, D.J.7
Holmberg, S.D.8
-
115
-
-
0242440877
-
Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells
-
Park W.S., Hayafune M., Miyano-Kurosaki N., Takaku H. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther. 2003, 10(24):2046-2050.
-
(2003)
Gene Ther.
, vol.10
, Issue.24
, pp. 2046-2050
-
-
Park, W.S.1
Hayafune, M.2
Miyano-Kurosaki, N.3
Takaku, H.4
-
116
-
-
38049187707
-
Reprogramming of human somatic cells to pluripotency with defined factors
-
Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451(7175):141-146.
-
(2008)
Nature
, vol.451
, Issue.7175
, pp. 141-146
-
-
Park, I.H.1
Zhao, R.2
West, J.A.3
Yabuuchi, A.4
Huo, H.5
Ince, T.A.6
Lerou, P.H.7
Lensch, M.W.8
Daley, G.Q.9
-
117
-
-
18144380714
-
Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor
-
Perez E.E., Riley J.L., Carroll R.G., von Laer D., June C.H. Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor. Clin. Immunol. 2005, 115(1):26-32.
-
(2005)
Clin. Immunol.
, vol.115
, Issue.1
, pp. 26-32
-
-
Perez, E.E.1
Riley, J.L.2
Carroll, R.G.3
von Laer, D.4
June, C.H.5
-
118
-
-
46949095221
-
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
-
Perez E.E., Wang J., Miller J.C., Jouvenot Y., Kim K.A., Liu O., Wang N., Lee G., Bartsevich V.V., Lee Y.L., Guschin D.Y., Rupniewski I., Waite A.J., Carpenito C., Carroll R.G., Orange J.S., Urnov F.D., Rebar E.J., Ando D., Gregory P.D., Riley J.L., Holmes M.C., June C.H. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol. 2008, 26(7):808-816.
-
(2008)
Nat. Biotechnol.
, vol.26
, Issue.7
, pp. 808-816
-
-
Perez, E.E.1
Wang, J.2
Miller, J.C.3
Jouvenot, Y.4
Kim, K.A.5
Liu, O.6
Wang, N.7
Lee, G.8
Bartsevich, V.V.9
Lee, Y.L.10
Guschin, D.Y.11
Rupniewski, I.12
Waite, A.J.13
Carpenito, C.14
Carroll, R.G.15
Orange, J.S.16
Urnov, F.D.17
Rebar, E.J.18
Ando, D.19
Gregory, P.D.20
Riley, J.L.21
Holmes, M.C.22
June, C.H.23
more..
-
119
-
-
0024307348
-
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen
-
Pircher H., Burki K., Lang R., Hengartner H., Zinkernagel R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989, 342(6249):559-561.
-
(1989)
Nature
, vol.342
, Issue.6249
, pp. 559-561
-
-
Pircher, H.1
Burki, K.2
Lang, R.3
Hengartner, H.4
Zinkernagel, R.M.5
-
120
-
-
20844440241
-
Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells
-
Podsakoff G.M., Engel B.C., Carbonaro D.A., Choi C., Smogorzewska E.M., Bauer G., Selander D., Csik S., Wilson K., Betts M.R., Koup R.A., Nabel G.J., Bishop K., King S., Schmidt M., von Kalle C., Church J.A., Kohn D.B. Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells. Mol. Ther. 2005, 12(1):77-86.
-
(2005)
Mol. Ther.
, vol.12
, Issue.1
, pp. 77-86
-
-
Podsakoff, G.M.1
Engel, B.C.2
Carbonaro, D.A.3
Choi, C.4
Smogorzewska, E.M.5
Bauer, G.6
Selander, D.7
Csik, S.8
Wilson, K.9
Betts, M.R.10
Koup, R.A.11
Nabel, G.J.12
Bishop, K.13
King, S.14
Schmidt, M.15
von Kalle, C.16
Church, J.A.17
Kohn, D.B.18
-
121
-
-
33644773580
-
Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA
-
Qureshi A., Zheng R., Parlett T., Shi X., Balaraman P., Cheloufi S., Murphy B., Guntermann C., Eagles P. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA. Biochem. J. 2006, 394(Pt 2):511-518.
-
(2006)
Biochem. J.
, vol.394
, Issue.PART 2
, pp. 511-518
-
-
Qureshi, A.1
Zheng, R.2
Parlett, T.3
Shi, X.4
Balaraman, P.5
Cheloufi, S.6
Murphy, B.7
Guntermann, C.8
Eagles, P.9
-
122
-
-
0030894132
-
32bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes
-
Rappaport J., Cho Y.Y., Hendel H., Schwartz E.J., Schachter F., Zagury J.F. 32bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes. Lancet 1997, 349(9056):922-923.
-
(1997)
Lancet
, vol.349
, Issue.9056
, pp. 922-923
-
-
Rappaport, J.1
Cho, Y.Y.2
Hendel, H.3
Schwartz, E.J.4
Schachter, F.5
Zagury, J.F.6
-
123
-
-
62249095476
-
The challenge of finding a cure for HIV infection
-
Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., Pomerantz R.J. The challenge of finding a cure for HIV infection. Science 2009, 323(5919):1304-1307.
-
(2009)
Science
, vol.323
, Issue.5919
, pp. 1304-1307
-
-
Richman, D.D.1
Margolis, D.M.2
Delaney, M.3
Greene, W.C.4
Hazuda, D.5
Pomerantz, R.J.6
-
124
-
-
0026648439
-
Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
-
Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992, 257(5067):238-241.
-
(1992)
Science
, vol.257
, Issue.5067
, pp. 238-241
-
-
Riddell, S.R.1
Watanabe, K.S.2
Goodrich, J.M.3
Li, C.R.4
Agha, M.E.5
Greenberg, P.D.6
-
125
-
-
0028079896
-
Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors
-
Roberts M.R., Qin L., Zhang D., Smith D.H., Tran A.C., Dull T.J., Groopman J.E., Capon D.J., Byrn R.A., Finer M.H. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. Blood 1994, 84(9):2878-2889.
-
(1994)
Blood
, vol.84
, Issue.9
, pp. 2878-2889
-
-
Roberts, M.R.1
Qin, L.2
Zhang, D.3
Smith, D.H.4
Tran, A.C.5
Dull, T.J.6
Groopman, J.E.7
Capon, D.J.8
Byrn, R.A.9
Finer, M.H.10
-
126
-
-
1842430906
-
Shedding light on immunotherapy for cancer
-
Rosenberg S.A. Shedding light on immunotherapy for cancer. N. Engl. J. Med. 2004, 350(14):1461-1463.
-
(2004)
N. Engl. J. Med.
, vol.350
, Issue.14
, pp. 1461-1463
-
-
Rosenberg, S.A.1
-
127
-
-
77957577506
-
Of mice, not men: no evidence for graft-versus-host disease in humans receiving T-cell receptor-transduced autologous T cells
-
Rosenberg S.A. Of mice, not men: no evidence for graft-versus-host disease in humans receiving T-cell receptor-transduced autologous T cells. Mol. Ther. 2010, 18(10):1744-1745.
-
(2010)
Mol. Ther.
, vol.18
, Issue.10
, pp. 1744-1745
-
-
Rosenberg, S.A.1
-
128
-
-
41149097574
-
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
-
Rosenberg S.A., Restifo N.P., Yang J.C., Morgan R.A., Dudley M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 2008, 8(4):299-308.
-
(2008)
Nat. Rev. Cancer
, vol.8
, Issue.4
, pp. 299-308
-
-
Rosenberg, S.A.1
Restifo, N.P.2
Yang, J.C.3
Morgan, R.A.4
Dudley, M.E.5
-
130
-
-
65249101637
-
The promise and potential pitfalls of chimeric antigen receptors
-
Sadelain M., Brentjens R., Riviere I. The promise and potential pitfalls of chimeric antigen receptors. Curr. Opin. Immunol. 2009, 21(2):215-223.
-
(2009)
Curr. Opin. Immunol.
, vol.21
, Issue.2
, pp. 215-223
-
-
Sadelain, M.1
Brentjens, R.2
Riviere, I.3
-
131
-
-
0025363891
-
Ribozymes as potential anti-HIV-1 therapeutic agents
-
Sarver N., Cantin E.M., Chang P.S., Zaia J.A., Ladne P.A., Stephens D.A., Rossi J.J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 1990, 247(4947):1222-1225.
-
(1990)
Science
, vol.247
, Issue.4947
, pp. 1222-1225
-
-
Sarver, N.1
Cantin, E.M.2
Chang, P.S.3
Zaia, J.A.4
Ladne, P.A.5
Stephens, D.A.6
Rossi, J.J.7
-
132
-
-
3242876747
-
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
-
Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430(6999):569-573.
-
(2004)
Nature
, vol.430
, Issue.6999
, pp. 569-573
-
-
Sayah, D.M.1
Sokolskaja, E.2
Berthoux, L.3
Luban, J.4
-
133
-
-
77953124494
-
Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs
-
Schopman N.C., ter Brake O., Berkhout B. Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010, 7:52.
-
(2010)
Retrovirology
, vol.7
, pp. 52
-
-
Schopman, N.C.1
ter Brake, O.2
Berkhout, B.3
-
134
-
-
1642380210
-
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)
-
Schrofelbauer B., Chen D., Landau N.R. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl Acad. Sci. USA 2004, 101(11):3927-3932.
-
(2004)
Proc. Natl Acad. Sci. USA
, vol.101
, Issue.11
, pp. 3927-3932
-
-
Schrofelbauer, B.1
Chen, D.2
Landau, N.R.3
-
135
-
-
39549117574
-
HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region
-
Senserrich J., Pauls E., Armand-Ugon M., Clotet-Codina I., Moncunill G., Clotet B., Este J.A. HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region. Virology 2008, 372(2):421-429.
-
(2008)
Virology
, vol.372
, Issue.2
, pp. 421-429
-
-
Senserrich, J.1
Pauls, E.2
Armand-Ugon, M.3
Clotet-Codina, I.4
Moncunill, G.5
Clotet, B.6
Este, J.A.7
-
136
-
-
0037043699
-
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
-
Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418(6898):646-650.
-
(2002)
Nature
, vol.418
, Issue.6898
, pp. 646-650
-
-
Sheehy, A.M.1
Gaddis, N.C.2
Choi, J.D.3
Malim, M.H.4
-
137
-
-
0032907674
-
Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
-
Shibata R., Igarashi T., Haigwood N., Buckler-White A., Ogert R., Ross W., Willey R., Cho M.W., Martin M.A. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 1999, 5(2):204-210.
-
(1999)
Nat. Med.
, vol.5
, Issue.2
, pp. 204-210
-
-
Shibata, R.1
Igarashi, T.2
Haigwood, N.3
Buckler-White, A.4
Ogert, R.5
Ross, W.6
Willey, R.7
Cho, M.W.8
Martin, M.A.9
-
138
-
-
77949885010
-
A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model
-
Shimizu S., Hong P., Arumugam B., Pokomo L., Boyer J., Koizumi N., Kittipongdaja P., Chen A., Bristol G., Galic Z., Zack J.A., Yang O., Chen I.S., Lee B., An D.S. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood 2010, 115(8):1534-1544.
-
(2010)
Blood
, vol.115
, Issue.8
, pp. 1534-1544
-
-
Shimizu, S.1
Hong, P.2
Arumugam, B.3
Pokomo, L.4
Boyer, J.5
Koizumi, N.6
Kittipongdaja, P.7
Chen, A.8
Bristol, G.9
Galic, Z.10
Zack, J.A.11
Yang, O.12
Chen, I.S.13
Lee, B.14
An, D.S.15
-
139
-
-
0030861904
-
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study
-
Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., Goedert J.J., O'Brien T.R., Jacobson L.P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M.W., O'Brien S.J. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997, 277(5328):959-965.
-
(1997)
Science
, vol.277
, Issue.5328
, pp. 959-965
-
-
Smith, M.W.1
Dean, M.2
Carrington, M.3
Winkler, C.4
Huttley, G.A.5
Lomb, D.A.6
Goedert, J.J.7
O'Brien, T.R.8
Jacobson, L.P.9
Kaslow, R.10
Buchbinder, S.11
Vittinghoff, E.12
Vlahov, D.13
Hoots, K.14
Hilgartner, M.W.15
O'Brien, S.J.16
-
140
-
-
0034681197
-
Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion
-
Steinberger P., Andris-Widhopf J., Buhler B., Torbett B.E., Barbas C.F. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc. Natl Acad. Sci. USA 2000, 97(2):805-810.
-
(2000)
Proc. Natl Acad. Sci. USA
, vol.97
, Issue.2
, pp. 805-810
-
-
Steinberger, P.1
Andris-Widhopf, J.2
Buhler, B.3
Torbett, B.E.4
Barbas, C.F.5
-
141
-
-
70350738592
-
Human cellular restriction factors that target HIV-1 replication
-
Strebel K., Luban J., Jeang K.T. Human cellular restriction factors that target HIV-1 replication. BMC Med. 2009, 7:48.
-
(2009)
BMC Med.
, vol.7
, pp. 48
-
-
Strebel, K.1
Luban, J.2
Jeang, K.T.3
-
142
-
-
1542288934
-
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys
-
Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
-
(2004)
Nature
, vol.427
, Issue.6977
, pp. 848-853
-
-
Stremlau, M.1
Owens, C.M.2
Perron, M.J.3
Kiessling, M.4
Autissier, P.5
Sodroski, J.6
-
143
-
-
13944259674
-
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction
-
Stremlau M., Perron M., Welikala S., Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 2005, 79(5):3139-3145.
-
(2005)
J. Virol.
, vol.79
, Issue.5
, pp. 3139-3145
-
-
Stremlau, M.1
Perron, M.2
Welikala, S.3
Sodroski, J.4
-
144
-
-
69449093055
-
Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes
-
Subramanian N., Mani P., Roy S., Gnanasundram S.V., Sarkar D.P., Das S. Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes. J. Gen. Virol. 2009, 90(Pt 8):1812-1819.
-
(2009)
J. Gen. Virol.
, vol.90
, Issue.PART 8
, pp. 1812-1819
-
-
Subramanian, N.1
Mani, P.2
Roy, S.3
Gnanasundram, S.V.4
Sarkar, D.P.5
Das, S.6
-
145
-
-
0025188193
-
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
-
Sullenger B.A., Gallardo H.F., Ungers G.E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 1990, 63(3):601-608.
-
(1990)
Cell
, vol.63
, Issue.3
, pp. 601-608
-
-
Sullenger, B.A.1
Gallardo, H.F.2
Ungers, G.E.3
Gilboa, E.4
-
146
-
-
33745941234
-
T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery
-
Swan C.H., Buhler B., Steinberger P., Tschan M.P., Barbas C.F., Torbett B.E. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Ther. 2006, 13(20):1480-1492.
-
(2006)
Gene Ther.
, vol.13
, Issue.20
, pp. 1480-1492
-
-
Swan, C.H.1
Buhler, B.2
Steinberger, P.3
Tschan, M.P.4
Barbas, C.F.5
Torbett, B.E.6
-
147
-
-
36248966518
-
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
-
Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
-
(2007)
Cell
, vol.131
, Issue.5
, pp. 861-872
-
-
Takahashi, K.1
Tanabe, K.2
Ohnuki, M.3
Narita, M.4
Ichisaka, T.5
Tomoda, K.6
Yamanaka, S.7
-
148
-
-
33751001588
-
Silencing of HIV-1 with RNA interference: a multiple shRNA approach
-
ter Brake O., Konstantinova P., Ceylan M., Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 2006, 14(6):883-892.
-
(2006)
Mol. Ther.
, vol.14
, Issue.6
, pp. 883-892
-
-
ter Brake, O.1
Konstantinova, P.2
Ceylan, M.3
Berkhout, B.4
-
149
-
-
38449086723
-
CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate
-
Tian S., Maile R., Collins E.J., Frelinger J.A. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J. Immunol. 2007, 179(5):2952-2960.
-
(2007)
J. Immunol.
, vol.179
, Issue.5
, pp. 2952-2960
-
-
Tian, S.1
Maile, R.2
Collins, E.J.3
Frelinger, J.A.4
-
150
-
-
67449132064
-
Generation of T cells from human embryonic stem cell-derived hematopoietic zones
-
Timmermans F., Velghe I., Vanwalleghem L., De Smedt M., Van Coppernolle S., Taghon T., Moore H.D., Leclercq G., Langerak A.W., Kerre T., Plum J., Vandekerckhove B. Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J. Immunol. 2009, 182(11):6879-6888.
-
(2009)
J. Immunol.
, vol.182
, Issue.11
, pp. 6879-6888
-
-
Timmermans, F.1
Velghe, I.2
Vanwalleghem, L.3
De Smedt, M.4
Van Coppernolle, S.5
Taghon, T.6
Moore, H.D.7
Leclercq, G.8
Langerak, A.W.9
Kerre, T.10
Plum, J.11
Vandekerckhove, B.12
-
151
-
-
20944446452
-
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
-
Trkola A., Kuster H., Rusert P., Joos B., Fischer M., Leemann C., Manrique A., Huber M., Rehr M., Oxenius A., Weber R., Stiegler G., Vcelar B., Katinger H., Aceto L., Gunthard H.F. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat. Med. 2005, 11(6):615-622.
-
(2005)
Nat. Med.
, vol.11
, Issue.6
, pp. 615-622
-
-
Trkola, A.1
Kuster, H.2
Rusert, P.3
Joos, B.4
Fischer, M.5
Leemann, C.6
Manrique, A.7
Huber, M.8
Rehr, M.9
Oxenius, A.10
Weber, R.11
Stiegler, G.12
Vcelar, B.13
Katinger, H.14
Aceto, L.15
Gunthard, H.F.16
-
152
-
-
77954633050
-
HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals
-
Trono D., Van Lint C., Rouzioux C., Verdin E., Barre-Sinoussi F., Chun T.W., Chomont N. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science 2010, 329(5988):174-180.
-
(2010)
Science
, vol.329
, Issue.5988
, pp. 174-180
-
-
Trono, D.1
Van Lint, C.2
Rouzioux, C.3
Verdin, E.4
Barre-Sinoussi, F.5
Chun, T.W.6
Chomont, N.7
-
153
-
-
84857959077
-
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response
-
Troyer R.M., McNevin J., Liu Y., Zhang S.C., Krizan R.W., Abraha A., Tebit D.M., Zhao H., Avila S., Lobritz M.A., McElrath M.J., Le Gall S., Mullins J.I., Arts E.J. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 2009, 5(4):e1000365.
-
(2009)
PLoS Pathog.
, vol.5
, Issue.4
-
-
Troyer, R.M.1
McNevin, J.2
Liu, Y.3
Zhang, S.C.4
Krizan, R.W.5
Abraha, A.6
Tebit, D.M.7
Zhao, H.8
Avila, S.9
Lobritz, M.A.10
McElrath, M.J.11
Le Gall, S.12
Mullins, J.I.13
Arts, E.J.14
-
154
-
-
36549043268
-
Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors
-
van Lent A.U., Nagasawa M., van Loenen M.M., Schotte R., Schumacher T.N., Heemskerk M.H., Spits H., Legrand N. Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors. J. Immunol. 2007, 179(8):4959-4968.
-
(2007)
J. Immunol.
, vol.179
, Issue.8
, pp. 4959-4968
-
-
van Lent, A.U.1
Nagasawa, M.2
van Loenen, M.M.3
Schotte, R.4
Schumacher, T.N.5
Heemskerk, M.H.6
Spits, H.7
Legrand, N.8
-
155
-
-
77954651556
-
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
-
van Loenen M.M., de Boer R., Amir A.L., Hagedoorn R.S., Volbeda G.L., Willemze R., van Rood J.J., Falkenburg J.H., Heemskerk M.H. Mixed T cell receptor dimers harbor potentially harmful neoreactivity. Proc. Natl Acad. Sci. USA 2010, 107(24):10972-10977.
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, Issue.24
, pp. 10972-10977
-
-
van Loenen, M.M.1
de Boer, R.2
Amir, A.L.3
Hagedoorn, R.S.4
Volbeda, G.L.5
Willemze, R.6
van Rood, J.J.7
Falkenburg, J.H.8
Heemskerk, M.H.9
-
156
-
-
34247208235
-
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus
-
van Lunzen J., Glaunsinger T., Stahmer I., von Baehr V., Baum C., Schilz A., Kuehlcke K., Naundorf S., Martinius H., Hermann F., Giroglou T., Newrzela S., Muller I., Brauer F., Brandenburg G., Alexandrov A., von Laer D. Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol. Ther. 2007, 15(5):1024-1033.
-
(2007)
Mol. Ther.
, vol.15
, Issue.5
, pp. 1024-1033
-
-
van Lunzen, J.1
Glaunsinger, T.2
Stahmer, I.3
von Baehr, V.4
Baum, C.5
Schilz, A.6
Kuehlcke, K.7
Naundorf, S.8
Martinius, H.9
Hermann, F.10
Giroglou, T.11
Newrzela, S.12
Muller, I.13
Brauer, F.14
Brandenburg, G.15
Alexandrov, A.16
von Laer, D.17
-
157
-
-
57349118383
-
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
-
Varela-Rohena A., Molloy P.E., Dunn S.M., Li Y., Suhoski M.M., Carroll R.G., Milicic A., Mahon T., Sutton D.H., Laugel B., Moysey R., Cameron B.J., Vuidepot A., Purbhoo M.A., Cole D.K., Phillips R.E., June C.H., Jakobsen B.K., Sewell A.K., Riley J.L. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat. Med. 2008, 14(12):1390-1395.
-
(2008)
Nat. Med.
, vol.14
, Issue.12
, pp. 1390-1395
-
-
Varela-Rohena, A.1
Molloy, P.E.2
Dunn, S.M.3
Li, Y.4
Suhoski, M.M.5
Carroll, R.G.6
Milicic, A.7
Mahon, T.8
Sutton, D.H.9
Laugel, B.10
Moysey, R.11
Cameron, B.J.12
Vuidepot, A.13
Purbhoo, M.A.14
Cole, D.K.15
Phillips, R.E.16
June, C.H.17
Jakobsen, B.K.18
Sewell, A.K.19
Riley, J.L.20
more..
-
158
-
-
42149101112
-
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species
-
Virgen C.A., Kratovac Z., Bieniasz P.D., Hatziioannou T. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl Acad. Sci. USA 2008, 105(9):3563-3568.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.9
, pp. 3563-3568
-
-
Virgen, C.A.1
Kratovac, Z.2
Bieniasz, P.D.3
Hatziioannou, T.4
-
159
-
-
77954734865
-
Antiretroviral therapy and management of HIV infection
-
Volberding P.A., Deeks S.G. Antiretroviral therapy and management of HIV infection. Lancet 2010, 376(9734):49-62.
-
(2010)
Lancet
, vol.376
, Issue.9734
, pp. 49-62
-
-
Volberding, P.A.1
Deeks, S.G.2
-
160
-
-
18344406935
-
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection
-
Walker R.E., Bechtel C.M., Natarajan V., Baseler M., Hege K.M., Metcalf J.A., Stevens R., Hazen A., Blaese R.M., Chen C.C., Leitman S.F., Palensky J., Wittes J., Davey R.T., Falloon J., Polis M.A., Kovacs J.A., Broad D.F., Levine B.L., Roberts M.R., Masur H., Lane H.C. Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood 2000, 96(2):467-474.
-
(2000)
Blood
, vol.96
, Issue.2
, pp. 467-474
-
-
Walker, R.E.1
Bechtel, C.M.2
Natarajan, V.3
Baseler, M.4
Hege, K.M.5
Metcalf, J.A.6
Stevens, R.7
Hazen, A.8
Blaese, R.M.9
Chen, C.C.10
Leitman, S.F.11
Palensky, J.12
Wittes, J.13
Davey, R.T.14
Falloon, J.15
Polis, M.A.16
Kovacs, J.A.17
Broad, D.F.18
Levine, B.L.19
Roberts, M.R.20
Masur, H.21
Lane, H.C.22
more..
-
161
-
-
65349127714
-
Virus-specific CD8 T cells: activation, differentiation and memory formation
-
Wiesel M., Walton S., Richter K., Oxenius A. Virus-specific CD8 T cells: activation, differentiation and memory formation. APMIS 2009, 117(5-6):356-381.
-
(2009)
APMIS
, vol.117
, Issue.5-6
, pp. 356-381
-
-
Wiesel, M.1
Walton, S.2
Richter, K.3
Oxenius, A.4
-
162
-
-
42149103799
-
Independent evolution of an antiviral TRIMCyp in rhesus macaques
-
Wilson S.J., Webb B.L., Ylinen L.M., Verschoor E., Heeney J.L., Towers G.J. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl Acad. Sci. USA 2008, 105(9):3557-3562.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.9
, pp. 3557-3562
-
-
Wilson, S.J.1
Webb, B.L.2
Ylinen, L.M.3
Verschoor, E.4
Heeney, J.L.5
Towers, G.J.6
-
163
-
-
1842732157
-
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion
-
Xu H., Svarovskaia E.S., Barr R., Zhang Y., Khan M.A., Strebel K., Pathak V.K. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl Acad. Sci. USA 2004, 101(15):5652-5657.
-
(2004)
Proc. Natl Acad. Sci. USA
, vol.101
, Issue.15
, pp. 5652-5657
-
-
Xu, H.1
Svarovskaia, E.S.2
Barr, R.3
Zhang, Y.4
Khan, M.A.5
Strebel, K.6
Pathak, V.K.7
-
164
-
-
15444378447
-
Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells
-
Yang L., Baltimore D. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc. Natl Acad. Sci. USA 2005, 102(12):4518-4523.
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, Issue.12
, pp. 4518-4523
-
-
Yang, L.1
Baltimore, D.2
-
165
-
-
0030881697
-
Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells
-
Yang O.O., Tran A.C., Kalams S.A., Johnson R.P., Roberts M.R., Walker B.D. Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells. Proc. Natl Acad. Sci. USA 1997, 94(21):11478-11483.
-
(1997)
Proc. Natl Acad. Sci. USA
, vol.94
, Issue.21
, pp. 11478-11483
-
-
Yang, O.O.1
Tran, A.C.2
Kalams, S.A.3
Johnson, R.P.4
Roberts, M.R.5
Walker, B.D.6
-
166
-
-
0037197973
-
Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells
-
Yang L., Qin X.F., Baltimore D., Van Parijs L. Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proc. Natl Acad. Sci. USA 2002, 99(9):6204-6209.
-
(2002)
Proc. Natl Acad. Sci. USA
, vol.99
, Issue.9
, pp. 6204-6209
-
-
Yang, L.1
Qin, X.F.2
Baltimore, D.3
Van Parijs, L.4
-
167
-
-
11844278251
-
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction
-
Yap M.W., Nisole S., Stoye J.P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 2005, 15(1):73-78.
-
(2005)
Curr. Biol.
, vol.15
, Issue.1
, pp. 73-78
-
-
Yap, M.W.1
Nisole, S.2
Stoye, J.P.3
-
168
-
-
36749043230
-
Induced pluripotent stem cell lines derived from human somatic cells
-
Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
-
(2007)
Science
, vol.318
, Issue.5858
, pp. 1917-1920
-
-
Yu, J.1
Vodyanik, M.A.2
Smuga-Otto, K.3
Antosiewicz-Bourget, J.4
Frane, J.L.5
Tian, S.6
Nie, J.7
Jonsdottir, G.A.8
Ruotti, V.9
Stewart, R.10
Slukvin, I.I.11
Thomson, J.A.12
-
169
-
-
42349097028
-
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy
-
Zhang H., Snyder K.M., Suhoski M.M., Maus M.V., Kapoor V., June C.H., Mackall C.L. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. J. Immunol. 2007, 179(7):4910-4918.
-
(2007)
J. Immunol.
, vol.179
, Issue.7
, pp. 4910-4918
-
-
Zhang, H.1
Snyder, K.M.2
Suhoski, M.M.3
Maus, M.V.4
Kapoor, V.5
June, C.H.6
Mackall, C.L.7
-
170
-
-
34047267005
-
Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling
-
Zhao Y., Parkhurst M.R., Zheng Z., Cohen C.J., Riley J.P., Gattinoni L., Restifo N.P., Rosenberg S.A., Morgan R.A. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res. 2007, 67(6):2425-2429.
-
(2007)
Cancer Res.
, vol.67
, Issue.6
, pp. 2425-2429
-
-
Zhao, Y.1
Parkhurst, M.R.2
Zheng, Z.3
Cohen, C.J.4
Riley, J.P.5
Gattinoni, L.6
Restifo, N.P.7
Rosenberg, S.A.8
Morgan, R.A.9
-
171
-
-
9944222768
-
Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4
-
Zhou N., Fang J., Mukhtar M., Acheampong E., Pomerantz R.J. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Gene Ther. 2004, 11(23):1703-1712.
-
(2004)
Gene Ther.
, vol.11
, Issue.23
, pp. 1703-1712
-
-
Zhou, N.1
Fang, J.2
Mukhtar, M.3
Acheampong, E.4
Pomerantz, R.J.5
-
172
-
-
11344251911
-
Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
-
Zhou J., Dudley M.E., Rosenberg S.A., Robbins P.F. Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J. Immunother. 2005, 28(1):53-62.
-
(2005)
J. Immunother.
, vol.28
, Issue.1
, pp. 53-62
-
-
Zhou, J.1
Dudley, M.E.2
Rosenberg, S.A.3
Robbins, P.F.4
|